Athena

Trial description
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Contact name
Dr Christine Parkinson
Trial start date
Wednesday, March 27, 2019
Trial end date
Friday, March 31, 2023
Trial tumour type
Gynaecological
Show on Radiotherapy
No